Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy

Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy

2016 September 15 | Se Jin Im, Masao Hashimoto, Michael Y. Gerner, Junghwa Lee, Haydn T. Kissick, Matheus C. Burger, Qiang Shan, J. Scott Hale, Judong Lee, Tahseen H. Nasti, Arlene H. Sharpe, Gordon J. Freeman, Ronald N. Germain, Helder I. Nakaya, Hai-Hui Xue, Rafi Ahmed
This study identifies a unique population of CD8⁺ T cells that proliferate after PD-1 pathway blockade in mice chronically infected with lymphocytic choriomeningitis virus (LCMV). These cells express PD-1 and several costimulatory molecules, including ICOS and CD28, and have a gene signature similar to CD4⁺ T follicular helper (TFH) cells, CD8⁺ memory precursors, and hematopoietic stem cell progenitors. They are found predominantly in lymphoid tissues, particularly in the T cell zones, and resemble stem cells during chronic infection, undergoing self-renewal and differentiating into terminally exhausted CD8⁺ T cells. The proliferative burst after PD-1 blockade comes almost exclusively from this CD8⁺ T cell subset. The transcription factor TCF1 plays a cell intrinsic and essential role in the generation of this CD8⁺ T cell subset. These findings provide a better understanding of T cell exhaustion and have implications for optimizing PD-1-directed immunotherapy in chronic infections and cancer. The study also shows that these CD8⁺ T cells are distinct from other exhausted CD8⁺ T cells and have a unique transcriptional program, which may represent a specific adaptation of CD8⁺ T cells to chronic antigenic stimulation. The identification of these cells has implications for understanding immune responses in autoimmunity and cancer. The study highlights the importance of PD-1 pathway blockade in restoring function in exhausted CD8⁺ T cells and improving immunotherapy outcomes in chronic infections and cancer.This study identifies a unique population of CD8⁺ T cells that proliferate after PD-1 pathway blockade in mice chronically infected with lymphocytic choriomeningitis virus (LCMV). These cells express PD-1 and several costimulatory molecules, including ICOS and CD28, and have a gene signature similar to CD4⁺ T follicular helper (TFH) cells, CD8⁺ memory precursors, and hematopoietic stem cell progenitors. They are found predominantly in lymphoid tissues, particularly in the T cell zones, and resemble stem cells during chronic infection, undergoing self-renewal and differentiating into terminally exhausted CD8⁺ T cells. The proliferative burst after PD-1 blockade comes almost exclusively from this CD8⁺ T cell subset. The transcription factor TCF1 plays a cell intrinsic and essential role in the generation of this CD8⁺ T cell subset. These findings provide a better understanding of T cell exhaustion and have implications for optimizing PD-1-directed immunotherapy in chronic infections and cancer. The study also shows that these CD8⁺ T cells are distinct from other exhausted CD8⁺ T cells and have a unique transcriptional program, which may represent a specific adaptation of CD8⁺ T cells to chronic antigenic stimulation. The identification of these cells has implications for understanding immune responses in autoimmunity and cancer. The study highlights the importance of PD-1 pathway blockade in restoring function in exhausted CD8⁺ T cells and improving immunotherapy outcomes in chronic infections and cancer.
Reach us at info@study.space